01513 LIVZON PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.23X | Oper Margin | 24.0% |
|---|---|---|---|
| LT Debt/Equity | 5.5% | Net Margin | 16.8% |
| Total Debt/Equity | 20.8% | Return on Equity | 14.6% |
| Price/Book | 1.58X | Return on Assets | 8.4% |
| (HKD 27.320) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 2,252.08 | 2,191.98 | 2,153.31 | 2,140.83 | 2,171.84 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +2.7 | +1.8 | +0.6 | -1.4 | +6.7 |
| Earnings Per Share (HKD) | 2.522 | 2.382 | 2.318 | 2.29 | 2.322 |
| Earnings Per Share Growth (%) | +5.9 | +2.8 | +1.2 | -1.4 | +6.8 |
| Dividend Per Share (HKD) | 1.592 | 1.199 | 1.482 | 1.744 | 1.512 |
| P/E* (X) | 10.72 | 11.35 | 11.67 | 11.81 | 11.65 |
| Yield (%) | 5.89 | 4.43 | 5.48 | 6.45 | 5.59 |
| Dividend Share (%) | 63.12 | 50.33 | 63.95 | 76.16 | 65.10 |
| Book NAV (HKD) | 17.099 | 16.177 | 16.752 | 16.630 | 16.959 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-19 21:00:20
Latest Result
| (RMBMn) | 2026-03 | 2025-03 | Chg* (%) | 2024-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 2,871 | 3,181 | -9.7 | 3,243 |
| Operating Result | 829.419 | 944.871 | -12.2 | 834.666 |
| Associates | 24.818 | 14.14 | +75.5 | 13.914 |
| Profit Before Taxation | 851.709 | 958.59 | -11.1 | 844.441 |
| Taxation | 127.7 | 154.948 | -17.6 | 128.362 |
| Profit /( Loss) After Taxation | 724.009 | 803.642 | -9.9 | 716.079 |
| Minority Interests | 147.101 | 166.934 | -11.9 | 108.255 |
| Net Profit | 576.909 | 636.708 | -9.4 | 607.824 |
| Earnings Per Share () | 0.7378 | 0.7617 | -3.1 | 0.7041 |
| Announcement Date | 2026-04-23 | 2025-04-23 | NA | 2024-04-23 |
* Annualised
Last Update Time: 2026-05-19 21:00:26
